Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance of the Abbott RealTime and Roche Cobas TaqMan hepatitis C virus (HCV) assays for quantification of HCV genotypes.

Journal of clinical microbiology - 1 May 2012

LaRue Heidi, Rigali Lisa, Balada-Llasat Joan-Miquel, Pancholi Preeti

Abstract excerpt

We evaluated the Abbott RealTime (ART) and Roche Cobas TaqMan Hepatitis C virus (HCV) viral load assays for quantification of HCV genotypes in patient specimens. The ART HCV assay was a more sensitive and precise tool for accurate HCV viral load quantification across the HCV genotypes tested, especially genotype 1b.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Hepacivirus
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C virus research

Share to Molecular Diagnostic Techniques

Share to Reagent Kits, Diagnostic

Share to Sensitivity and Specificity

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 22378914
DOI: 10.1128/JCM.06723-11
PMCID: PMC3347146

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance of the Abbott RealTime and Roche Cobas TaqMan hepatitis C virus (HCV) assays for quantification of HCV genotypes.PMID 22378914Read ↗

Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.Semantic proximity Read ↗

Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus GenotypingSemantic proximity Read ↗

Performance of the COBAS® AmpliPrep/COBAS TaqMan® automated system for hepatitis C virus (HCV) quantification in a multi-center comparison.Semantic proximity Read ↗

A real-time Taqman method for hepatitis C virus genotyping and methods for further subtyping of isolates.Semantic proximity Read ↗

COBAS ® AmpliPrep/COBAS ® Taqman ® HCV Quantitative Test, version 2.0: an in vitro test for hepatitis C virus RNA quantification.Semantic proximity Read ↗

Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.Semantic proximity Read ↗

Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.Semantic proximity Read ↗

Comparative performance of two commercial sample-to-result systems for hepatitis C virus quantitation and genotyping.Semantic proximity Read ↗

Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.Semantic proximity Read ↗

HCV RNA detection in HCV antibody-positive patients with the COBAS AmpliPrep/COBAS TaqMan HCV test, v2.0 in comparison with FDA-approved nucleic acid tests.Semantic proximity Read ↗

Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.Semantic proximity Read ↗

A multicenter evaluation of the Abbott RealTime HCV Genotype II assay.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.